We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
-2.47%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$235B
AUM Growth
-$9.94B
Cap. Flow
-$1.24B
Cap. Flow %
-0.53%
Top 10 Hldgs %
24.41%
Holding
3,241
New
78
Increased
1,054
Reduced
1,506
Closed
57

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$595M
2
VRSK icon
Verisk Analytics
VRSK
+$499M
3
OTIS icon
Otis Worldwide
OTIS
+$484M
4
LULU icon
lululemon athletica
LULU
+$408M
5
MSFT icon
Microsoft
MSFT
+$346M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$384M
2
NKE icon
Nike
NKE
+$341M
3
ANET icon
Arista Networks
ANET
+$335M
4
V icon
Visa
V
+$331M
5
CTSH icon
Cognizant
CTSH
+$308M

Sector Composition

Rank Sector Weight
1 Technology 27.66%
2 Healthcare 18%
3 Financials 11.03%
4 Consumer Discretionary 10.25%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLX icon
3151
Protalix BioTherapeutics
PLX
$194M
$38.8K ﹤0.01%
23,400
WKHS icon
3152
Workhorse Group
WKHS
$30.3M
$38.8K ﹤0.01%
31
COOK icon
3153
Traeger
COOK
$169M
$36.7K ﹤0.01%
269
+64
+31% +$13.6K
RAIN
3154
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$36.7K ﹤0.01%
42,580
DHX icon
3155
DHI Group
DHX
$168M
$36.5K ﹤0.01%
11,920
TLRY icon
3156
Tilray
TLRY
$494M
$35.2K ﹤0.01%
1,471
DZSI
3157
DELISTED
DZS Inc. Common Stock
DZSI
$34.7K ﹤0.01%
16,540
INVZ icon
3158
Innoviz Technologies
INVZ
$136M
$34.4K ﹤0.01%
17,660
OMER icon
3159
Omeros
OMER
$835M
$34.2K ﹤0.01%
11,700
GRTS
3160
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$31K ﹤0.01%
18,000
SRTA
3161
Strata Critical Medical Inc
SRTA
$435M
$30.9K ﹤0.01%
11,940
PIII icon
3162
P3 Health Partners
PIII
$35.6M
$29.6K ﹤0.01%
403
CMPX icon
3163
Compass Therapeutics
CMPX
$387M
$26.6K ﹤0.01%
13,480
+2,220
+20% +$5.49K
UP icon
3164
Wheels Up
UP
$213M
$26.1K ﹤0.01%
631
IPSC icon
3165
Century Therapeutics
IPSC
$382M
$25.4K ﹤0.01%
12,680
BHIL
3166
DELISTED
Benson Hill, Inc.
BHIL
$25.3K ﹤0.01%
2,178
+50
+2% +$1.55K
OTLK icon
3167
Outlook Therapeutics
OTLK
$202M
$23.9K ﹤0.01%
5,399
-572
-10% -$12.7K
BKSY icon
3168
BlackSky Technology
BKSY
$808M
$22.4K ﹤0.01%
2,394
-1,111
-32% -$14.1K
MKTW icon
3169
MarketWise
MKTW
$53.3M
$21.4K ﹤0.01%
670
-52
-7% -$1.76K
LCTX icon
3170
Lineage Cell Therapeutics
LCTX
$254M
$20.9K ﹤0.01%
17,730
+4,790
+37% +$6.52K
AKTS
3171
DELISTED
Akoustis Technologies Inc
AKTS
$20.2K ﹤0.01%
26,810
RNAC icon
3172
Cartesian Therapeutics
RNAC
$234M
$18.3K ﹤0.01%
576
-181
-24% -$6.05K
PRST
3173
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$17.2K ﹤0.01%
12,020
QVCGA
3174
DELISTED
QVC Group Inc Series A
QVCGA
$13.3K ﹤0.01%
437
-1
-0.2% -$42
LILM
3175
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$12.9K ﹤0.01%
18,064

Similar funds

AllianceBernstein's Q3 2023 Portfolio in Review

As of Q3 2023, AllianceBernstein held 3,241 positions worth $235B, down 4.1% from $245B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.2%. AllianceBernstein opened 78 new positions and exited 57, leaving the 3,241-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • AllianceBernstein's largest Q3 2023 buy was CRH: 5,431,009 shares worth $297M.
  • AllianceBernstein added most to Netflix in Q3 2023, an estimated $595M increase.
  • AllianceBernstein's biggest Q3 2023 reduction was Apple, cutting an estimated $384M.
  • AllianceBernstein fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $77.5M.
  • AllianceBernstein's ten largest holdings make up 24% of its $235B portfolio in Q3 2023.
  • AllianceBernstein opened 78 new positions and closed 57 in Q3 2023.
  • AllianceBernstein's portfolio value fell 4.1% quarter-over-quarter to $235B.

Based on AllianceBernstein's 13F filing for Q3 2023, filed 14 Nov 2023.